Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.
2.

T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region.

Lemieux AM, Paré ME, Audet B, Legault E, Lefort S, Boucher N, Landry S, van Opijnen T, Berkhout B, Naghavi MH, Tremblay MJ, Barbeau B.

J Biol Chem. 2004 Dec 17;279(51):52949-60. Epub 2004 Oct 1.

3.
4.

Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.

Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.

J Virol. 1993 May;67(5):2853-61.

5.

Characterization and chromosomal mapping of the gene encoding the cellular DNA binding protein ILF.

Li C, Lusis AJ, Sparkes R, Nirula A, Gaynor R.

Genomics. 1992 Jul;13(3):665-71.

PMID:
1339390
7.

Characterization and chromosomal mapping of the gene encoding the cellular DNA binding protein HTLF.

Li C, Lusis AJ, Sparkes R, Tran SM, Gaynor R.

Genomics. 1992 Jul;13(3):658-64.

PMID:
1639393
8.
9.
10.

A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1.

Giacca M, Gutierrez MI, Menzo S, d'Adda di Fagagna F, Falaschi A.

Virology. 1992 Jan;186(1):133-47.

PMID:
1727595
13.

The RRM domain of MINT, a novel Msx2 binding protein, recognizes and regulates the rat osteocalcin promoter.

Newberry EP, Latifi T, Towler DA.

Biochemistry. 1999 Aug 17;38(33):10678-90.

PMID:
10451362
14.

Molecular mechanism of NFAT family proteins for differential regulation of the IL-2 and TNF-alpha promoters.

Oum JH, Han J, Myung H, Hleb M, Sharma S, Park J.

Mol Cells. 2002 Feb 28;13(1):77-84.

15.

NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.

Cron RQ, Bartz SR, Clausell A, Bort SJ, Klebanoff SJ, Lewis DB.

Clin Immunol. 2000 Mar;94(3):179-91.

PMID:
10692237
18.

Regulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene products.

Muchardt C, Seeler JS, Nirula A, Shurland DL, Gaynor RB.

J Virol. 1992 Jan;66(1):244-50.

19.

Supplemental Content

Support Center